Color doppler ultrasound assessment of juxta-anastomotic stenosis in radiocephalic arteriovenous fistulas: endovascular or surgical approach

• Autor(a) principal: Pimentel,Ana
• Data de Publicação: 2018
• Outros Autores: Almeida,Paulo, de Matos,Norton, Loureiro,Luís, Teixeira,Gabriela, Rego,Duarte, Teixeira,Sérgio, Pinheiro,Joaquim, Fonseca,Isabel, Carvalho,Telmo, Queirós,José
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692018000100005
• topic: Assisted primary patency; color doppler ultrasound; juxta-anastomotic stenosis, neo-anastomosis; percutaneous transluminal angioplasty; primary patency

Background: Juxta-anastomotic stenosis (JAS) is a common complication of radiocephalic arteriovenous fistulas. There is diverging data as to the best therapeutic approach being angioplasty or surgery. Pre-operative color Doppler ultrasound (CDU) is accurately used for initial assessment of the vascular access and follow-up monitoring. The aim of this study was to evaluate immediate and long-term results of endovascular versus open surgical intervention of juxta-anastomotic venous stenosis of forearm radiocephalic fistulas and to test if CDU assessment can be used to ameliorate preoperative strategy and long-term outcomes. Methods: This retrospective cohort study included 63 patients with JAS radiocephalic fistulas referred to vascular access consultation. CDU was used to assess preoperative morphological, functional and hemodynamic stenosis characteristics and according to specific criteria, allocate patients to endovascular or surgical treatment. Results: Surgical revision was proposed in 68.2% of patients (N=43), namely the creation of a new proximal fistula (N=41), while angiographic evaluation was proposed in 31.7% of the cases (N=20). Mean follow-up time was 720±524 days with a maximum follow-up of 4.6 years. In the surgical group, primary patency was 92% and 84% at 6 and 12 months respectively, while in the endovascular group, it was 76% and 47% (p=0.013). There was no significant difference in the assisted primary patency between the interventional groups at 12 months: 94% in the endovascular vs. 93% in the surgical group (p=0.542). Conclusion: Pre-operative CDU assessment of JAS and specific allocation criteria with an access-centered approach choosing the best option in each fistula allowed the correct diagnosis of the lesion, improved the global results of the treatment and optimized the financial resources by reserving PTA for selected cases where surgery could be more difficult with higher risk of access loss